| Catalog Number |
SSF-240 |
| Medical Device Problem Code |
Device Appears to Trigger Rejection (1524)
|
| Health Effect - Clinical Code |
Capsular Contracture (1761)
|
| Date of Event |
10/07/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Healthcare professional reported "right side capsular contracture, baker grade iv," the device remains implanted.
|
| |
|
Additional Manufacturer Narrative
|
|
The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture baker grade iv.A review of the device history record has been completed.No deviations or non-conformances noted.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional, changed, and/or corrected data: b5, d6b, h.6.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional, changed, and/or corrected data: h11.Fi summary:
the review of the documentation associated to the manufacturing process indicates that all devices involved in this work order were released in accordance with abbvie¿s procedures and were no defects/problems/issues found in the documents or in the personnel training related to the reported event.Additionally, no er/ ncr(s) were identified during the investigation associated with this lot and the complaint.According to the device analysis performed in the laboratory was observed a split (ss) in patch area, it is out of specification per qa 199.04.The event of capsular contracture was unable to observed, and the workmanship has not relation to reported complaint.Therefore, the reported events was not confirmed.A review of the current risk documents pfmea-silicone filled bi and sizer assembly, smooth rev 3.0 was performed, and the event of split in patch is a known event, for which current process controls and inspections are established to reduce the incidence of this defect.Considering that there is no adverse trend for this type of event, no additional actions are deemed required at this time.The issue with split in patch will continue to be monitored and corrective actions will be taken in the future if deemed appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional, changed, and/or corrected data: d9, h3, h6.Device evaluation:
per the analysis performed, the assessments of the complaints and any potential manufacturing issue are displayed along with any further actions required:
¿ capsular contracture: unable to observe through visual inspection as it is a physiological phenomenon.A workmanship was observed through visual inspection not related to the complaint for a observed split in patch area event.A further investigation is requested.None of the other observations performed during the device analysis deformation and creases are found to be potentially related to the manufacturing process, and, therefore, no further actions are required for these observations.
|
| |
|
Search Alerts/Recalls
|